|
Ruiz-Nodar JM, Marín F, Sánchez-Payá J, Hurtado JA, Valencia-Martín J, Manzano-Fernández S, Roldán V, Pérez-Andreu V, Sogorb F, Valdés M, Lip GY. Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation. Eur Heart J. 2009 Apr;30(8):932-9. doi: 10.1093/eurheartj/ehp045. Epub 2009 Feb 26. PubMed PMID: 19246502.
AÑO: 2009; IF: 9.8
|
19246502
|
Gimeno JR, Monserrat L, Pérez-Sánchez I, Marín F, Caballero L, Hermida-Prieto M, Castro A, Valdés M. Hypertrophic cardiomyopathy. A study of the troponin-T gene in 127 Spanish families. Rev Esp Cardiol. 2009 Dec;62(12):1473-7. PubMed PMID: 20038417.
AÑO: 2009; IF: 2.746
|
|
Roldán V, Ordoñez A, Marín F, Zorio E, Soria JM, Miñano A, España F, González-Conejero R, Pineda J, Estellés A, Fontcuberta J, Vicente V, Corral J. Antithrombin Cambridge II (A384S) supports a role for antithrombin deficiency in arterial thrombosis. Thromb Haemost. 2009 Mar;101(3):483-6. PubMed PMID: 19277409.
AÑO: 2009; IF: 4.451
|
|
Pastor-Pérez FJ, Rivera J, Lozano ML, Marín F. Does the Holy Grail escape us again? Eur Heart J. 2009 May;30(9):1152. doi: 10.1093/eurheartj/ehp137. Epub 2009 Apr 2. PubMed PMID: 19342395.
AÑO: 2009; IF: 9.8
|
|
Sandín M., Marín F., Cambronero F., Climent V., Caro C., Martínez J.G., Honrubia A.G., Alberola A.G., de la Morena G., Valdés M., Sogorb F. Does Pacemaker Implantation Provide Long-Term Benefits in Severe Obstructive Hypertrophic Cardiomyopathy?. Revista Espanola de Cardiologia. November 2009. 62:1233-1239. 10.1016/S0300-8932(09)73075-1
AÑO: 2009; IF: 2.746
|